Guangzhou Kingmed Diagnostics Group Co., Ltd.

¥28.63As of Sun 8 Nov 2026, 12:00 UTC
SSE:603882Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (2.68%)
Div yield 3.07%
ROE 4.71%
Diagnostics & Research
Beta (5Y) 0.36
PE TTM 47.34
TSR TTM (1.55%)
Mkt cap ¥13.07B
ROIC 6.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥36
25.61%
7.41%
Sell 1|4|1|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.44
0.47
0.47
0.51
(1.78%)
7.56%
11.20%
13.89%
Revenue¥B
1.402
1.461
1.423
1.435
(2.45%)
4.35%
(2.70%)
1.05%
Peers (US$1.960B)
Cap (US$)
PE
1.125B
30.08x
1.950B
15.78x
Capital
TTM
5Y
10Y
Leveragex
0.908
0.689
0.512
EBIT/Intx
0.973
0.080
0.088
Own earn%
(77.01)
(86.29)
(74.95)
Sh yield%
36.56
30.76
31.30
Owners
Insiders/Inst%
5.04
70.50
Short interest%
2.01
SBC / revenue%
5.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
15–19
$1 testx
0.0
Incr. ROIC%
4